Clarivate and Relatable Healthcare Forge Strategic Partnership to Transform Medtech Sales Contracting Process

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Clarivate Medtech Intelligence and Relatable software enhance product data management and competitive conversion efficiency for medtech sales, contracting and pricing teams

LONDON, Sept. 23, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced a strategic partnership with Relatable Healthcare, a technology company delivering Product Relationship Management (PRM) software to leading medtech companies to drive revenue and workflow efficiency.

Relatable™ is a Product Relationship Management (PRM) platform created for medtech manufacturers and distributors to unlock new competitive conversion capabilities that drive cost-efficient revenue growth. The platform establishes a single source of truth for all information associated with specific products and their direct competitors, populating a data management platform available to contracting, sales, marketing and technical support teams.

Within the Relatable™ platform, customers can now access comprehensive competitive intelligence from Clarivate in addition to product specifications and cross-references, inventory availability, sales collateral, EPP data, chemicals of concern, manufacturing origin, or any custom proprietary data a customer wishes to manage.  This partnership empowers Clarivate and Relatable clients to make confident strategic pricing decisions, streamline sales contracting processes, and enhance contract compliance by offering comprehensive tools and insights to manage the entire contracting cycle effectively. 

Andrew Lee, Vice President Medtech, Life Sciences & Healthcare, Clarivate, said: “At Clarivate, we are focused on expanding our market intelligence and data analytics offering in the medical device and technology sectors while providing powerful workflow solutions that turn data-driven insights into decisions and actions that accelerate growth for our clients. This new strategic partnership enables us to support the industry in getting products to patients faster.”

Joshua Emert, CEO of Relatable Healthcare, said: “At Relatable Healthcare, we are dedicated to creating intuitive software that modernizes how innovative medical device and supply companies leverage product intelligence to drive efficient revenue growth. We are excited to partner with Clarivate and its medtech customers to automate workflows across contracting, sales, marketing and product support. This will enable instant cross-referencing of competitive products in RFP responses, more frequent measurement of contract compliance and proactive discovery of conversion opportunities in the field.”

In an evolving healthcare landscape, medical device and supply companies, along with their distributors, face significant challenges in communicating their product value and offering consultative insights. They also struggle with driving adoption and analyzing market trends effectively. Cost-constrained healthcare providers rigorously evaluate purchasing decisions, comparing devices and supplies in detail. To meet this demand, medtech companies require up-to-date competitive intelligence and advanced software to analyze and communicate tailored portfolio insights for each contracting, sales and conversion opportunity.

This collaboration enables medtech companies to commercialize products and serve Integrated Delivery Networks (IDNs), Group Purchasing Organizations (GPOs), health systems and independent hospitals, surgery centers and clinics, streamlining the entire revenue growth process more efficiently. Combining the deep product-level market knowledge of Clarivate with enterprise software by Relatable Healthcare equips medtech companies with the insights and tools to win new business and drive contract compliance.

About Clarivate

Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

About Relatable Healthcare

Relatable Healthcare is a technology company delivering pioneering Product Relationship Management (PRM) solutions for the medical device and supply industry. Our data management tools and automated workflows help leading MedTech organizations drive efficient revenue growth across the commercialization spectrum. For more information, please visit www.relatable.io

Media Contact:
Luna Ivkovic,
External Communications, Life Sciences & Healthcare
newsroom@clarivate.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-and-relatable-healthcare-forge-strategic-partnership-to-transform-medtech-sales-contracting-process-302253754.html

SOURCE Clarivate Plc

Staff

Recent Posts

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

16 hours ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

16 hours ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

16 hours ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

16 hours ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

16 hours ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…

16 hours ago